Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Poltreg's change in inventory for the quarter that ended in Mar. 2026 was zł-0.18 Mil. It means Poltreg's inventory
increased by zł0.18 Mil
from Dec. 2025 to Mar. 2026 .
Poltreg's change in inventory for the fiscal year that ended in Dec. 2025 was zł-0.44 Mil. It means Poltreg's inventory
increased by zł0.44 Mil
from Dec. 2024 to Dec. 2025 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Poltreg's Days Inventory for the quarter that ended in Mar. 2026 was 84.56.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Poltreg's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.08.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Poltreg's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Poltreg Change In Inventory Related Terms
Poltreg Change In Inventory Historical Data
* Premium members only.
The historical data trend for Poltreg's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Inventory of zł-0.44 Mil mean?
Poltreg (WAR:PTG) has a Change In Inventory of zł-0.44 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Poltreg and its competitors.
Is Poltreg's Change In Inventory too high?
Poltreg's current Change In Inventory is zł-0.44 Mil. Overall, Poltreg has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Poltreg's Change In Inventory compare to VRTX and REGN?
Poltreg's Change In Inventory of zł-0.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Poltreg and its competitors. Poltreg's current Change In Inventory is zł-0.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poltreg stock overvalued right now?
Based on GuruFocus' analysis, Poltreg (WAR:PTG) is currently considered Significantly Overvalued. The stock's GF Value™ is zł14.20, compared to a current price of zł23.10 — trading 62.7% above its estimated fair value. The current Change In Inventory is zł-0.44 Mil. Poltreg's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Poltreg (WAR:PTG), the current Change In Inventory is zł-0.44 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poltreg (WAR:PTG) Overvalued in 2026?
Based on GuruFocus' analysis, Poltreg stock appears to be overvalued.
The current stock price of zł23.10 is trading 62.7% above its estimated GF Value™ of zł14.20.
GuruFocus considers Poltreg to be Significantly Overvalued.
Key valuation signals for WAR:PTG:
Change In Inventory: zł-0.44 Mil
GF Value™: zł14.20 vs. price of zł23.10 (62.7% above fair value)
No single metric tells the full story. See the WAR:PTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.
46GF Score
Get the complete analysis for WAR:PTG
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PTG has been successfully added to your 
